Intelence 100 mg Tablets

    Intelence 100 mg Tablets

    S4
    PDF Leaflet Revision Date: 08 March 2024


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of HIV-1 infection in antiretroviral treatment-experienced patients.

    Dosage (summary)

    200 mg (two 100 mg tablets) orally twice daily with food.

    Special Populations

    • Elderly
    • Hepatic impairment
    • Renal impairment

    Pregnancy & Breastfeeding

    Not recommended during pregnancy; avoid breastfeeding while on INTELENCE.

    Key Drug Interactions

    • Carbamazepine
    • Phenobarbital
    • Phenytoin
    • Rifampicin
    • St. John's wort

    Contraindications

    • Hypersensitivity to etravirine or excipients

    Common side effects

    • Rash
    • Diarrhoea
    • Nausea
    • Hypertriglyceridaemia

    Counselling Points

    • Take with food
    • Do not miss doses
    • Monitor for rash or hypersensitivity

    Serious warnings

    • Severe skin reactions
    • Hypersensitivity reactions
    • Immune reconstitution syndrome
    Important Disclaimer

    The Intelence 100 mg Tablets professional information leaflet below is the property of Janssen Pharmaceutica (Pty) Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn